Manfredini Daniele, Piccotti Fabio, Guarda-Nardini Luca
Department of Maxillofacial Surgery, University of Padova, Italy.
Cranio. 2010 Jul;28(3):166-76. doi: 10.1179/crn.2010.023.
Hyaluronate acid (HA) injections are gaining attention as a treatment option to manage symptoms of temporomandibular joint (TMJ) disorders, but updated evidence-based data on their effectiveness are actually lacking. The present paper aims to summarize and review systematically the clinical studies on the use of hyaluronic acid injections to treat TMJ disorders performed over the last decade. On November 9, 2009, a systematic search in the National Library of Medicine's PubMed (http://www.ncbi.nlm.nih.gov/pubmed) database was performed by means of a combined MeSH and word terms to identify all peer-reviewed papers published in the English literature dealing with the hyaluronic acid infiltration in patients affected by TMJ disorders. The selected papers were assessed according to a structured reading of articles format, which provided that the study design was methodologically evaluated in relation to four main issues, viz., population, intervention, comparison, and outcome. Nineteen (N=19) papers were selected for inclusion in the review, twelve (N=12) dealt with the use of hyaluronic acid in TMJ disk displacements and seven (N=7) dealt with inflammatory-degenerative disorders. Only nine groups of researchers were involved in the studies, and less than half of the studies (8/19) were randomized and controlled trials (RCTs). All studies reported a decrease in pain levels independently by the patients' disorder and by the adopted injection protocol. Positive outcomes were maintained over the follow-up period, which was varied among studies, ranging between 15 days and 24 months. The superiority of HA injections was shown only against placebo saline injections, but outcomes are comparable with those achieved with corticosteroid injections or oral appliances. The available literature seems to be inconclusive as to the effectiveness of HA injections with respect to other therapeutic modalities in treating TMJ disorders. Studies with a better methodological design are needed to gain better insight into this issue and to draw clinically useful information on the most suitable protocols for each different TMJ disorder.
透明质酸(HA)注射作为一种治疗颞下颌关节(TMJ)紊乱症状的治疗选择正受到关注,但实际上缺乏关于其有效性的最新循证数据。本文旨在系统总结和回顾过去十年中使用透明质酸注射治疗TMJ紊乱的临床研究。2009年11月9日,通过医学主题词(MeSH)和关键词组合在国立医学图书馆的PubMed(http://www.ncbi.nlm.nih.gov/pubmed)数据库中进行了系统检索,以识别英文文献中所有关于TMJ紊乱患者透明质酸注射的同行评审论文。根据文章格式的结构化阅读对所选论文进行评估,这要求从四个主要方面对研究设计进行方法学评估,即人群、干预、对照和结果。19篇论文被选入综述,其中12篇涉及透明质酸在TMJ盘移位中的应用,7篇涉及炎性退行性疾病。只有9组研究人员参与了这些研究,不到一半的研究(8/19)是随机对照试验(RCT)。所有研究均报告,无论患者的病情和采用的注射方案如何,疼痛水平均有所降低。在不同研究中随访期各不相同(15天至24个月)的随访期间,均保持了积极的结果。HA注射仅在与安慰剂盐水注射对比时显示出优势,但结果与皮质类固醇注射或口腔矫治器的结果相当。关于HA注射在治疗TMJ紊乱方面相对于其他治疗方式的有效性,现有文献似乎尚无定论。需要进行方法学设计更好的研究,以更深入地了解这个问题,并得出关于每种不同TMJ紊乱最合适方案的临床有用信息。